{"transactions":[{"id":731914,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:15:51.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":11.17,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001434647-26-000052","document":"wk-form4_1781813748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000052/wk-form4_1781813748.xml","form_type":"4"}},{"id":1129161,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:39:55.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019048","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774925019048/rdgdoc.xml","form_type":"4"}},{"id":1374028,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-11-06T21:54:39.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":120968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120968,"derivative":{"exercise_price":0.62,"exercise_date":"2025-10-14","expiration_date":"2034-11-04","underlying":"Common stock","underlying_shares":120968},"source":{"system":"sec-edgar","filing":"0001731122-24-001729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510445/000173112224001729/ownership.xml","form_type":"4"}},{"id":1515868,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T01:18:00.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":39200,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001437749-24-017181","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924017181/rdgdoc.xml","form_type":"4"}},{"id":1896647,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-12T00:02:59.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":58800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 3, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer."}],"balance_after":58800,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":58800},"source":{"system":"sec-edgar","filing":"0001437749-23-014014","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923014014/rdgdoc.xml","form_type":"4"}}]}